To replace Moore’s law, next month, the semiconductor industry will launch the International Roadmap for Devices and Systems, ending the International Technology Roadmap for Semiconductors. The strategy will focus on applications and the chips needed for them. The Semiconductor Industry Association will follow its own strategy. Under Moore’s law, as circuits got smaller, they began […]

According to Food Processing’s 15th annual Manufacturing Outlook Survey, published this month, which surveyed 251 food professionals in October–November 2015, 29% of respondents were very optimistic about the industry in 2016 and 49% were somewhat optimistic. As for their capital spending outlook for 2016, 22% chose “don’t know,” followed by 17% that predict an increase […]

There is a growing trend toward QA in labs. QC systems are integral to virtually all commercial goods and services, and certain clinical application labs implement these systems (such as Good Clinical Practice, Good Manufacturing Practice and Good Laboratory Practice) for data submission to regulatory agencies. A QA group, Quality Central, launched in 2009, now […]

On January 16, the National Human Genome Research Institute (NHGRI), part of the NIH, launched the Centers for Common Disease Genomics (CCDG) to study the genetic factors that make up common and uncommon human diseases. The CCDG is an extension of the NHGRI’s flagship Genome Sequencing program, which focused on wide ranging genome sequencing projects. […]

According to the Biotechnology Industry Organization (BIO), the EPA’s final rule for the 2014–2016 Renewable Fuel Standards (RFS) is “unnecessary and unlawful.” BIO stated that the EPA’s two-year delay in implementing the rule will continue to damage investment in advanced and cellulosic biofuels, and will increase greenhouse gas emissions in transportation-fuel sectors. The RFS ensure […]

A survey of 52 pharmaceutical industry and academic personnel involved in natural products (NP) drug discovery found a gap between NP drug discovery strategies and NP drug potential. Thirty-five respondents chose high-throughput screening (HTS) as the “top preferred current strategy.” However, it is not best suited for NP drug discovery, according to many respondents. For […]

Earlier this month, DuPont and Dow Chemical announced an all-stock merger valued at $130 billion. The union will be split into three new companies: a materials science company; a specialty products company targeting the electronics, communications, safety and protection industries; and an agriculture firm. Dow shareholders will own 52% of the new company, while DuPont […]

According to a new report by Deloitte, R&D return on investments generated from the pharmaceutical industry’s annual investment in new product innovation have continued to decline. The annual projected R&D returns were 10.1% in 2010; in 2015, the returns were down to 4.2%. Since 2010, Deloitte’s original cohort of 12 companies has launched 186 products […]

The NSF has released preliminary figures for the US federal government’s budget authority for fiscal 2015. Total R&D and R&D-plant budget authority grew 0.7% to $137.2 billion in current dollars, down from 2.8% growth in fiscal 2014. Adjusted for inflation, both years’ levels are nearly flat with fiscal 2010. Nondefense R&D and R&D-plant budget authority […]